Alison Fiander

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer

Leszek K. Borysiewicz, Alison Fiander, M. Nimako et al. · The Lancet · 1996 · 530 citations

Life Sciences, Infectious Diseases, Oncology +15

Differences in human papillomavirus type distribution in high‐grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe

Wiebren Tjalma, Alison Fiander, Olaf Reich et al. · International Journal of Cancer · 2012 · 221 citations · Full text

Medicine, Oncology, Pathology +17

Human papillomavirus prevalence and type‐distribution in cervical glandular neoplasias: Results from a <scp>E</scp>uropean multinational epidemiological study

Katsiaryna Holl, Andrzej Nowakowski, Ned Powell et al. · International Journal of Cancer · 2015 · 150 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Immunological Responses in Women with Human Papillomavirus Type 16 (HPV-16)-Associated Anogenital Intraepithelial Neoplasia Induced by Heterologous Prime-Boost HPV-16 Oncogene Vaccination

Lucy J.C. Smyth, Mariëtte I.E. van Poelgeest, Emma J. Davidson et al. · Clinical Cancer Research · 2004 · 127 citations · Full text

Medicine, Immunology, Oncology +17

Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial

Amanda Tristram, Tracie Madden, Ned Powell et al. · The Lancet Oncology · 2014 · 106 citations · Full text

Medicine, Dermatology, Surgery +15